According to our latest study on “Poultry Vaccines Market Forecast to 2028 – COVID-19 Impact Analysis – by Type, Technology, Dosage Form, Route of Administration, Disease, and End User,” the market is expected to grow from US$ 1,844.89 million in 2021 to US$ 2,845.00 million by 2028; it is estimated to grow at a CAGR of 6.4% from 2021 to 2028. The report highlights the key factors driving the market growth and prominent players with their developments in the poultry vaccines market.

Get Sample PDF Brochure of Poultry Vaccines Market Size - COVID-19 Impact and Global Analysis with Strategic Developments at: https://www.theinsightpartners.com/sample/TIPRE00004772/

The growing demand for healthy chicken food in Europe, the Middle East & Africa (EMEA) encourages governments to create suitable laws and regulations for the safety of animals in the poultry business. For example, infections with Campylobacter and Salmonella species are the two most common foodborne illnesses caused by eating chicken meat. The instances of influenza H5N1 infection in humans are linked to the consumption of raw or undercooked chicken or chicken products (HPAI). Based on demands, there has been a rise in the production of poultry products in the EMEA. With the rise in demand for poultry food products, the need for vaccines is on the rise to keep poultry safe and achieve optimum yields. However, the demand is decreasing in the poorer African countries. Poultry birds are susceptible to various fowl illnesses, which cause significant economic losses to the business, particularly in poorer nations.

According to the data published by the US department of agriculture (USDA), the country recorded a per capita poultry product consumption of 107.6 pounds in 2016, which increased to 113 pounds in 2021. This increase in production and consumption is one of the factors which is driving the poultry healthcare market. Technological advancements in vaccine manufacturing are also driving the global poultry vaccines market. For instance, in 2020, Boehringer Ingelheim’s Animal Health Business in the US launched the vaccine VAXXITEK HVT+IBD+ND that protects poultry from three diseases Marek’s Disease, infectious bursal disease (classic and variant types), and Newcastle disease. The business manufactures 60 billion doses of poultry vaccines in a year for use in the US and over 60 other countries, including Germany, Italy, China, and Japan.

Poultry vaccines are biological components (antigens) that provide active acquired immunity to specific poultry diseases. Another reason for poultry flock vaccination is hyper-immunizing hens to enhance the levels of maternally generated antibodies that are transferred through an egg to the hatching progeny.

The global poultry vaccines market is segmented on the basis of type, technology, dosage form, route of administration, disease, and end user. Based on type, the market is segmented into broiler, layer, and breeder. The breeder segment held the largest share of the global poultry vaccines market in 2021. Moreover, it is anticipated to register the highest CAGR during the forecast period. Based on technology, the global poultry vaccines market is categorized into live attenuated vaccines, inactivated vaccines, recombinant vaccines, and others. The live attenuated vaccines segment held the largest market share in 2021, and it is estimated to register the highest CAGR in the market during the forecast period. Based on dosage form, the global poultry vaccines market is segmented into liquid vaccines, freeze-dried vaccines, and dust/powdered vaccines. The liquid vaccines segment held the largest share of the market in 2021; it is estimated to register the highest CAGR during the forecast period. Based on the route of administration, the global poultry vaccines market is segmented into drinking water & spray, intramuscular, subcutaneous, and others. The drinking water & spray segment held the largest share of the market in 2021; and the market for this segment is estimated to grow at the fastest CAGR during the forecast period. Based on disease, the global poultry vaccines market is segmented into Infectious bronchitis, avian influenza, Marek's disease, infectious bursal disease, Newcastle disease, salmonellosis, and others. The Newcastle disease segment held the largest share of the market in 2021; however, the avian influenza segment is estimated to register the highest CAGR during the forecast period. Based on end user, the global poultry vaccines market is segmented into poultry farms & hatcheries, veterinary hospitals, and poultry vaccination centers & clinics. The poultry farms & hatcheries segment held the largest market share in 2021; moreover, the segment is estimated to register the highest CAGR during the forecast period.

Boehringer Ingelheim International GmbH; Zoetis Inc.; Ceva Santé Animale; BIOVAC; Phibro Animal Health Corporation; Hester Biosciences Limited; Venky's India; Dechra Pharmaceuticals PLC; Elanco; Merck Animal Health are among the leading companies operating in the global poultry vaccines market.

REPORT HIGHLIGHTS

Our report on Poultry Vaccines Market cover following key parameters:

Comprehensive market analysis at global, regional and country level

Detailed PEST (Political, Economic, Social and Technological) factors impacting the market across key geographic regions such as North America, Europe, Asia Pacific, Middle East & Africa, and South America

Market dynamics (drivers, restraints, opportunities, and future trends) and impact analysis of drivers and restraints at short-term, mid-term and long-term

In-depth market segmentation and deep dive regional and country level analysis of 18+ countries across 5 key regions

Key company profiles and industry landscape to provide latest market initiatives and competitive landscape

Impact of COVID`19 pandemic on ecosystem and the market

About Us:

The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact Us:

The Insight partners,

Phone: +1-646-491-9876

Email: sales@theinsightpartners.com